Arbutus Biopharma Corp Preferred Stock Dividends and Other Adjustments
Arbutus Biopharma Corp (ABUS) reported Preferred Stock Dividends and Other Adjustments of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2023-03-02
- Arbutus Biopharma Corp preferred stock dividends and other adjustments for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Arbutus Biopharma Corp preferred stock dividends and other adjustments for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Arbutus Biopharma Corp preferred stock dividends and other adjustments for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Arbutus Biopharma Corp preferred stock dividends and other adjustments for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Arbutus Biopharma Corp preferred stock dividends and other adjustments for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Arbutus Biopharma Corp preferred stock dividends and other adjustments for fiscal 2021 was $12.14M, a 0.13% increase from fiscal 2020.
- Arbutus Biopharma Corp preferred stock dividends and other adjustments for fiscal 2020 was $12.12M, a 8.74% increase from fiscal 2019.
- Arbutus Biopharma Corp preferred stock dividends and other adjustments for fiscal 2019 was $11.15M, a 10.48% increase from fiscal 2018.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | $0.00 10-K · filed 2023-03-02 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $574.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $574.00K derived: sum of 3 quarters · filed 2023-03-02 | $5.66M derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | $574.00K derived: sum of 2 quarters · filed 2023-03-02 | $5.66M derived: sum of 3 quarters · filed 2023-03-02 | $8.93M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-12-31 | $574.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $5.66M derived: sum of 2 quarters · filed 2023-03-02 | $8.93M derived: sum of 3 quarters · filed 2023-03-02 | $12.14M 10-K · filed 2023-03-02 |
| 2021-09-30 | $5.09M 10-Q · filed 2022-11-09 | $8.35M derived: sum of 2 quarters · filed 2022-11-09 | $11.56M 10-Q · filed 2022-11-09 | $14.69M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $3.27M 10-Q · filed 2022-08-04 | $6.48M 10-Q · filed 2022-08-04 | $9.60M derived: sum of 3 quarters · filed 2022-08-04 | $12.63M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $3.21M 10-Q · filed 2022-05-05 | $6.33M derived: sum of 2 quarters · filed 2022-05-05 | $9.36M derived: sum of 3 quarters · filed 2022-05-05 | $12.36M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $6.15M derived: sum of 2 quarters · filed 2022-03-03 | $9.14M derived: sum of 3 quarters · filed 2022-03-03 | $12.12M 10-K · filed 2022-03-03 |
| 2020-09-30 | $3.03M 10-Q · filed 2021-11-04 | $6.02M derived: sum of 2 quarters · filed 2021-11-04 | $9.00M 10-Q · filed 2021-11-04 | $11.88M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $3.00M 10-Q · filed 2021-08-05 | $5.97M 10-Q · filed 2021-08-05 | $8.85M derived: sum of 3 quarters · filed 2021-08-05 | $11.64M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $2.98M 10-Q · filed 2021-05-05 | $5.86M derived: sum of 2 quarters · filed 2021-05-05 | $8.65M derived: sum of 3 quarters · filed 2021-05-05 | $11.41M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $5.67M derived: sum of 2 quarters · filed 2021-03-04 | $8.43M derived: sum of 3 quarters · filed 2021-03-04 | $11.15M 10-K · filed 2021-03-04 |
| 2019-09-30 | $2.79M 10-Q · filed 2020-11-05 | $5.55M derived: sum of 2 quarters · filed 2020-11-05 | $8.27M 10-Q · filed 2020-11-05 | $10.92M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $2.76M 10-Q · filed 2020-08-07 | $5.48M 10-Q · filed 2020-08-07 | $8.12M derived: sum of 3 quarters · filed 2020-08-07 | $10.69M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $2.71M 10-Q · filed 2020-05-11 | $5.36M derived: sum of 2 quarters · filed 2020-05-11 | $7.93M derived: sum of 3 quarters · filed 2020-05-11 | $10.47M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $5.21M derived: sum of 2 quarters · filed 2020-03-05 | $7.75M derived: sum of 3 quarters · filed 2020-03-05 | $10.09M 10-K · filed 2020-03-05 |
| 2018-09-30 | $2.57M 10-Q · filed 2019-11-06 | $5.11M derived: sum of 2 quarters · filed 2019-11-06 | $7.44M 10-Q · filed 2019-11-06 | $8.36M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $2.54M 10-Q · filed 2019-08-05 | $4.88M 10-Q · filed 2019-08-05 | $5.79M derived: sum of 3 quarters · filed 2019-08-05 | $5.79M derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | $2.34M 10-Q · filed 2019-05-06 | $3.25M derived: sum of 2 quarters · filed 2019-05-06 | $3.25M derived: sum of 3 quarters · filed 2019-05-06 | $3.25M derived: sum of 4 quarters · filed 2019-05-06 |
| 2017-12-31 | $911.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $911.00K derived: sum of 2 quarters · filed 2019-03-07 | $911.00K derived: sum of 3 quarters · filed 2019-03-07 | $911.00K 10-K · filed 2019-03-07 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-03 | $0.00 10-Q · filed 2018-08-03 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-04 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-03-16 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |